Approval · Notice of Compliance 63 · 2004
VANIQA: Notice of Compliance 63
Issued February 3, 2004
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 63
- Date
- February 3, 2004
- Company
- Shire Biochem Inc.Saint Laurent, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Hair growth inhibitor
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| VANIQA | 02243837 | Marketed |
Medicinal ingredients
- EFLORNITHINE HYDROCHLORIDE 13.9 PER